(Rac)-MRI-1867 (Synonyms: (Rac)-MRI-1867) |
Katalog-Nr.GC63410 |
(Rac)-MRI-1867 ((Rac)-MRI-1867, Verbindung 6b) ist ein Cannabinoid-Rezeptor Typ 1 (CB1R)/iNOS-Antagonist mit einem Ki von 5,7 nM fÜr CB1R.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1610420-28-4
Sample solution is provided at 25 µL, 10mM.
(Rac)-MRI-1867 (compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-MRI-1867 is potential for the research of liver fibrosis[1].
[1]. Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB 1 R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis.
Average Rating: 5
(Based on Reviews and 40 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *